{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:01:26Z","timestamp":1778673686089,"version":"3.51.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Direct"],"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The demand for transplantable organs exceeds donor organ supply. Transplantation of organs from donors with a history of malignancy remains controversial and the transmission of cancer in liver transplant recipients has not been sufficiently examined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>From 2002 until 2017, 83 livers from donors with a history of malignancy were transplanted at the University Hospital Essen, Germany. Donor and recipient data, type of malignancy, tumor-free interval at organ procurement, and follow-up data were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Nine different tumor sites (central nervous system [n = 27], genitourinary [n = 24], breast [n = 10], skin [n = 8], colorectal [n = 5], lung [n = 3], hemato-oncological [n = 3], thyroid [n = 2], and larynx [n = 1]) were detected in 83 donors. The majority (58%) of donors had tumor-free intervals of less than 5 years versus 19% of 6 to 10 years versus 23% over 10 years. The risk of tumor transmission from donors was assessed as low in 44 (53%), intermediate in 28 (34%), and high in 11 (13%) cases. During median follow-up of 19.9 (0-155) months, none of the recipients developed donor-transmitted malignancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Liver transplantation with organs from donors with a medical history of malignancy is feasible, and the risk of donor-transmitted malignancy appears to be low in this single-center analysis. A careful selection of donors remains mandatory and can expand the donor pool.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000000738","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T17:00:43Z","timestamp":1508432443000},"page":"e224","source":"Crossref","is-referenced-by-count":16,"title":["Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience"],"prefix":"10.1097","volume":"3","author":[{"given":"Tamas","family":"Benk\u00f6","sequence":"first","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University Hospital of Essen, University Duisburg-Essen, Essen, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter P.","family":"Hoyer","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University Hospital of Essen, University Duisburg-Essen, Essen, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuat H.","family":"Saner","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University Hospital of Essen, University Duisburg-Essen, Essen, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen W.","family":"Treckmann","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University Hospital of Essen, University Duisburg-Essen, Essen, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University Hospital of Essen, University Duisburg-Essen, Essen, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Radunz","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University Hospital of Essen, University Duisburg-Essen, Essen, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2017,11]]},"reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/lt.21668","article-title":"Report of the Paris consensus meeting on expanded criteria donors in liver transplantation","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/SLA.0b013e31815c2a3f","article-title":"Use of severely steatotic grafts in liver transplantation: a matched case-control study","volume":"246","year":"2007","journal-title":"Ann Surg"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1478-3231.2011.02525.x","article-title":"Liver transplantation using donor organs with markedly elevated liver enzymes: how far can we go?","volume":"31","year":"2011","journal-title":"Liver Int"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.tp.0000267919.93425.fb","article-title":"Deceased donors with a past history of malignancy: an Organ Procurement And Transplantation Network\/United Network for Organ Sharing update","volume":"84","year":"2007","journal-title":"Transplantation"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1600-6143.2010.03130.x","article-title":"How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK Registry data","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00007890-200012270-00014","article-title":"First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer","volume":"70","year":"2000","journal-title":"Transplantation"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1111\/j.1600-6143.2012.04195.x","article-title":"The Eurotransplant Donor Risk Index in liver transplantation: ET-DRI","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index","volume":"6","year":"2006","journal-title":"Am J Transplant"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10561-007-9036-1","article-title":"Donor derived malignancy following transplantation: a review","volume":"8","year":"2007","journal-title":"Cell Tissue Bank"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/ajt.12192","article-title":"De novo cancer-related death in Australian liver and cardiothoracic transplant recipients","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/TP.0b013e318272df41","article-title":"Cancer transmission from organ donors\u2014unavoidable but low risk","volume":"94","year":"2012","journal-title":"Transplantation"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1600-6143.2009.02700.x","article-title":"Donor-derived disease transmission events in the United States: data reviewed by the OPTN\/UNOS Disease Transmission Advisory Committee","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.TP.0000076094.64973.D8","article-title":"Donors with central nervous system malignancies: are they truly safe?","volume":"76","year":"2003","journal-title":"Transplantation"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00007890-200202270-00017","article-title":"Transplant tumor registry: donors with central nervous system tumors1","volume":"73","year":"2002","journal-title":"Transplantation"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s10620-012-2501-0","article-title":"Donor-transmitted malignancy in a liver transplant recipient: a case report and review of literature","volume":"58","year":"2013","journal-title":"Dig Dis Sci"},{"key":"bib17-20231002","first-page":"75","article-title":"The need for vigilance in extended criteria donors with a past history of malignancy: a case report and review of literature","volume":"16","year":"2011","journal-title":"Ann Transplant"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/TP.0b013e31823f7f47","article-title":"Advising potential recipients on the use of organs from donors with primary central nervous system tumors","volume":"93","year":"2012","journal-title":"Transplantation"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/bjs.9460","article-title":"Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry","volume":"101","year":"2014","journal-title":"Br J Surg"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.transproceed.2009.03.046","article-title":"Liver transplantation utilizing grafts from donors with genitourinary cancer detected prior to liver implantation","volume":"41","year":"2009","journal-title":"Transplant Proc"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.lts.2003.09.024","article-title":"If the donor had an early-stage genitourinary carcinoma and the liver has already been implanted, should we perform the transplantectomy?","volume":"9","year":"2003","journal-title":"Liver Transpl"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1600-6143.2011.03565.x","article-title":"Donor-transmitted malignancies in organ transplantation: assessment of clinical risk","volume":"11","year":"2011","journal-title":"Am J Transplant"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01845228-201711000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:10:03Z","timestamp":1696230603000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01845228-201711000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":21,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000000738","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}